Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases
Annals of the Rheumatic Diseases · 2026-08
DOI: 10.1016/j.ard.2026.07.021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026-08. Verfasst von Nicolas Tchitchek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Inserm, UMRS 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France. Electronic address: nicolas.tchitchek@sorbonne-u…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institutes of Health Office of Research Infrastructure Programs, French National Research Agency, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Sorbonne Université, Inserm, UMRS 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France. Electronic address: nicolas.tchitchek@sorbonne-universite.fr.
- Sorbonne Université, Inserm, UMRS 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France; AP-HP, Clinical Investigation Center for Biotherapies, Pitié-Salpêtrière Hospital, Paris, France.
- Computational Sciences Department, The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
- Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL, USA.
- Sorbonne Université, Inserm, UMRS 959, Immunology-Immunopathology-Immunotherapy (i3), Paris, France; AP-HP, Clinical Investigation Center for Biotherapies, Pitié-Salpêtrière Hospital, Paris, France. Electronic address:…
Förderung
- National Institutes of Health Office of Research Infrastructure Programs
- French National Research Agency
- National Institutes of Health
Zitieren
APA
Tchitchek, N., Rosenzwajg, M., Lorenzon, R., Rinchai, D., Chaussabel, D., Malek, T. R., & Klatzmann, D. (2026). Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.07.021
Vancouver
Tchitchek N, Rosenzwajg M, Lorenzon R, Rinchai D, Chaussabel D, Malek TR, et al. Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.07.021
BibTeX
@article{Tchitchek2026,
author = {Tchitchek, Nicolas and Rosenzwajg, Michelle and Lorenzon, Roberta and Rinchai, Darawan and Chaussabel, Damien and Malek, Thomas R and Klatzmann, David},
title = {Interferon-stimulated gene signature predicts clinical response to low-dose IL-2 in immune-mediated inflammatory diseases},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2026.07.021}
}
EUVIMED